ClinicalTrials.gg
RecruitingNCT03758573IMTversusMVUpdated May 10, 2023

Effectiveness Inspirational Muscle Training

An interventional study of Inspiratory Muscle Training (IMT) and Intensive Physiotherapy (IPT) in Respiratory Insufficiency, sponsored by Universidade Federal do vale do São Francisco. Recruiting at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-10.

Sponsored by Universidade Federal do vale do São Francisco · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2019; still recruiting 7 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 39 studies in Respiratory Insufficiency with a site in Brazil — 7 open to participants now, 8 under way, none of them phase 3. Respiratory Insufficiency · Brazil.

Planned enrollment
19th of 35
40 · median 46
Started
2019
with 2 others
No phase
24 of 39
5 open now
Registered
18th of 39
by date

Among the 39 studies in Respiratory Insufficiency with a site in Brazil, this one is the 19th largest by planned enrollment of the 35 interventional ones that give a count, is one of 3 that started in 2019, is one of 24 with no phase, and was the 18th registered.

Respiratory Insufficiency

1,371 studies on the registry are indexed under Respiratory Insufficiency; 266 are open to participants now.

Browse Respiratory Insufficiency studies →

Open to participants now

7 of the 39 studies in Respiratory Insufficiency with a site in Brazil are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 180 Respiratory Insufficiency studies recruiting now, 135 (75%) set no upper age limit and 18 (10%) stop at 75 or younger; 21 take children under 18; 20 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Respiratory Insufficiency with a site in Brazil, or all of them as a file.
02

Study summary

The long stay in mechanical ventilation can induce several complications, among them respiratory muscle weakness, this has been related to the duration of mechanical ventilation, delay and failure to wean, resulting in longer hospitalization, which reflects in greater care increase in hospital costs. Therefore, of this research will be to compare the effectiveness of early inspiratory muscle training (IMT) versus non-IMT in patients undergoing mechanical ventilation to improve the outcome of mechanical ventilation weaning time.

Read the detailed description

The study will consist of a randomized controlled clinical trial conducted at the Intensive Care Unit of the University Hospital of UNIVASF. Will be included individuals of both sexes, aged 18 years or older, who are on invasive mechanical ventilation and who obtain the Free and Informed Consent Form, signed by the responsible family member. Subjects will be randomized into two groups (training and control). The inspiratory (MIP), expiratory (MEP) and peak expiratory flow pressures will be evaluated. The training group will perform respiratory muscle training, using the Powerbreath equipment, with initial loading of 40% of MIP, 7 days a week, 2 times a day. Morbidities that have repercussions on diaphragmatic contraction and end-stage disease will be used as exclusion criteria. The sample data will be analyzed through the SPSS 22.0 program. The significance level of the study will be set at 5% (p \<0.05).

03

Conditions studied

  • Respiratory Insufficiency

Keywords

  • Breathing Exercises
  • Respiratory Muscles
  • Respiration Artificial
  • Weaning
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • invasive mechanical ventilation
  • patients hemodynamically stable
  • without use of vasoactive drugs

Exclusion criteria

Exclusion Criteria:

  • spindle trauma
  • neuromuscular diseases
  • end-stage disease
  • pneumothorax
  • rib fracture
  • diaphragmatic injury
  • postoperative pulmonary surgeries
  • abdominal disease
  • morbidities that have repercussions on diaphragmatic contraction
  • mechanical ventilation with FiO2 > 60% and PEEP > 10 cm H2O
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Inspiratory Muscle Training (IMT)

    IMT by means of the Powerbreath equipment (Classic, London, UK), according to the following parameters: initial loading of 40% of MIP, 3 sets of 10 repetitions with interval of 1 minute between each sets, 7 days a week, 2 times a day , with the patients in the bed with the angulation of 45 °. The IMT load settings will be adjusted according to the values evaluated weekly. If there is need for addition of supplemental oxygen will be performed to perform the IMT.

    Other: Inspiratory Muscle Training (IMT)

  • Active comparator
    Intensive Physiotherapy (IPT)

    IPT will be to individualized and supervised intervention program consisting of any of the following procedures: passive, assisted, active or resisted mobilization, sedation and orthostasis depending on the functional level of the patient, as well as bronchial hygiene therapy and pulmonary expansion therapy.

    Other: Intensive Physiotherapy (IPT)

Interventions

  • OtherInspiratory Muscle Training (IMT)

    Inspiratory Muscle Training (IMT)

  • OtherIntensive Physiotherapy (IPT)

    Intensive Physiotherapy (IPT)

06

What researchers measure

Primary outcomes

  1. Weaning mechanical ventilation

    time of mechanical ventilation

    Time frame: through study completion, an average of 15 days

Secondary outcomes

  1. length of stay in the ICU

    reduction length of stay in the ICU

    Time frame: through study completion, an average of 15 days

  2. extubation success

    extubation success after 48 hours

    Time frame: through study completion, an average of 2 days

  3. death

    reduction in mortality (death)

    Time frame: yes or not death, through study completion, an average of 15 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Registration ClinicalTrials; Study Protocol; Paper results.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2019 (actual). Primary completion is estimated for Dec 2023, 59 months after the start.

Of 360 non-industry interventional studies with no phase under Respiratory Insufficiency, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's planned 59 months is above that.

Counting every sponsor, half of 376 studies reached it within 24 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 21, 2018
First posted
Nov 29, 2018
StartActual
Jan 15, 2019
Primary completionEst.
Dec 31, 2023
CompletionEst.
Dec 31, 2023
Last update
May 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03758573
Lead sponsor
Universidade Federal do vale do São Francisco
Responsible party
Rodrigo Gustavo da Silva Carvalho (Principal Investigator, Universidade Federal do vale do São Francisco) — Principal investigator
First posted
Nov 29, 2018
Start date
Jan 15, 2019
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
May 10, 2023

Study contacts

Rodrigo GS Carvalho, PhD
Contact
rodrigocarvalhofisio@gmail.com
+5587999832015
Rodrigo GS Carvalho, PhD
Contact
rodrigo.carvalho@univasf.edu.br
+558721016856
Rodrigo GS Carvalho, PhD
principal investigator · Physical Education College / UNIVASF

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion